Unmeasured confounding in pharmacoepidemiology.

Rolf H H Groenwold, Mark C H de Groot, Dhivya Ramamoorthy, Patrick C Souverein, Olaf H Klungel

Journal: Annals of epidemiology 2016;26(1):85-6

PMID: 26559329

Full Text on Elsevier Science View on PubMed

Abstract

Address: Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Utrecht, The Netherlands; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands. Electronic address: [email protected].; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Utrecht, The Netherlands.; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Utrecht, The Netherlands; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.

DOI: 10.1016/j.annepidem.2015.10.007

Link outs

Free resources

Medical:

https://medlineplus.gov/heartattack.html

Other Literature Sources:

https://scite.ai/reports/26559329

Subscription / membership required

Full Text Sources:

MeSH Terms: Adrenergic beta-2 Receptor Antagonists, Adult, Aged, Bias, Calcium Channel Blockers, Case-Control Studies, Confounding Factors, Epidemiologic, Epidemiologic Research Design, Humans, Logistic Models, Middle Aged, Myocardial Infarction, Odds Ratio, Pharmacoepidemiology, Propensity Score